29
total announcements
AGARWALEYE.NS · 15 min delayed
Key Stats · Yahoo Finance · as of 15 Oct 2026
Market Cap
₹14,834 Cr
P/E (TTM)
100.6
P/E (Forward)
55.6
EPS (TTM)
₹4.65
52W Low
₹401.00
52W High
₹568.00
Dividend Yield
0.00%
Price / Book
7.3
Debt / Equity
50.3
Revenue (TTM)
₹2,207 Cr
Gross Margin
43.61%
Operating Margin
15.00%
Dr. Agarwal's Health Care Limited
Dr. Agarwal's Health Care Limited has submitted a certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026, confirming the details of securities dematerialized/rematerialized during the period.
Dr. Agarwal's Health Care Limited
Dr. Agarwal's Health Care Limited has received sanction from the Hon'ble NCLT, Chennai Bench for the Scheme of Amalgamation between Dr. Agarwal's Eye Hospital Limited and Dr. Agarwal's Health Care Limited, effective from April 01, 2026.
Dr. Agarwal's Health Care Limited
Dr. Agarwal's Health Care Limited has received an update from its step-down wholly owned subsidiary in Nigeria, confirming that Orbit Healthcare Services Nigeria Ltd has become a wholly owned subsidiary of Orbit Healthcare Services (Mauritius) Limited, a direct wholly owned subsidiary of the Company.
Dr. Agarwal's Health Care Limited
Dr. Agarwal's Health Care Limited has informed the Exchange regarding Cessation of Mr. Sanjay Anand as Non-Executive Independent Director of the company w.e.f. September 29, 2026.
Dr. Agarwal's Health Care Limited
Dr. Agarwal's Health Care Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, due to the finalization and publication of the Unaudited Financial Results for the quarter and half year ending September 30, 2026.
Dr. Agarwal's Health Care Limited
Dr. Agarwal's Health Care Limited has announced the voting results and consolidated scrutinizer's report of its 16th Annual General Meeting (AGM), where all seven resolutions proposed were approved by the requisite majority of shareholders.
Dr. Agarwal's Health Care Limited
Dr. Agarwal's Health Care Limited held its 16th Annual General Meeting on September 21, 2026, through video conferencing. All resolutions were passed with the required majority, including the re-appointment of directors, auditor, and revisions in remuneration.
Dr. Agarwal's Health Care Limited
Dr. Agarwal's Health Care Limited has informed the Exchange about Copy of Newspaper Publication regarding the Sixteenth Annual General Meeting of the Company, Instructions for e-Voting and Other Related Information.
Dr. Agarwal's Health Care Limited
Dr. Agarwal's Health Care Limited has convened its 16th Annual General Meeting (AGM) for the financial year 2025-2026, to be held on September 21, 2026, through video conferencing. The meeting will consider the annual report and other business items. The company has also made its annual report available on its website.
Dr. Agarwal's Health Care Limited
Dr. Agarwal's Health Care Limited has launched the World's First Pinhole Pupilloplasty (PPP) Centre at its subsidiary Dr. Agarwal's Eye Hospital Limited in Chennai, India.
Dr. Agarwal's Health Care Limited
Dr. Agarwal's Health Care Limited has informed the Exchange about the schedule of analyst/investor meet and conferences to be held on September 16 and 17-18, 2026, in Gurgaon and Mumbai respectively.
Dr. Agarwal's Health Care Limited
Dr. Agarwal's Health Care Limited has informed the Exchange about the transcript of the discussion on the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2026, at the Analyst / Earnings conference call held on August 04, 2026. The transcript is available on the Company's website.
Dr. Agarwal's Health Care Limited
Dr. Agarwal's Health Care Limited has made available the audio recording of its analyst/earnings conference call for the quarter ended June 30, 2026, on its website.
Dr. Agarwal's Health Care Limited
Dr. Agarwal's Health Care Limited has submitted a Monitoring Agency Report for the quarter ended June 30, 2026, as per Regulation 32(6) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, and Regulation 41(4) of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. The report, issued by ICRA Limited, Monitoring Agency, confirms that the utilization of the proceeds of the Initial Public Offer (IPO) is in line with the objects of the issue.
Dr. Agarwal's Health Care Limited
Dr. Agarwal's Health Care Limited has informed the Exchange about Investor Presentation for Q1 FY27. The presentation includes unaudited financial results for the quarter ended June 30, 2026. The company has also scheduled an analyst/earnings conference call to discuss the results.
Dr. Agarwal's Health Care Limited
Dr. Agarwal's Health Care Limited announced its unaudited consolidated financial results for the quarter ended June 30, 2026, with revenue from operations growing by 26.0% YoY to ₹614 Crores, total income growing by 23.9% YoY to ₹620 Crores, IND-AS EBITDA growing by 25.2% YoY to ₹177 Crores, and PAT growing by 44.6% YoY to ₹55 Crores.
Dr. Agarwal's Health Care Limited
Dr. Agarwal's Health Care Limited has scheduled a board meeting on August 4, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026, and will host an earnings/analyst conference call to discuss the results.
Dr. Agarwal's Health Care Limited
Dr. Agarwal's Health Care Limited has published a newspaper advertisement for the Notice of hearing of the Company's Petition in relation to the Scheme of amalgamation between Dr. Agarwal's Eye Hospital Limited and Dr. Agarwal's Health Care Limited.
Dr. Agarwal's Health Care Limited
Dr. Agarwal's Health Care Limited has submitted a disclosure under SEBI Takeover Regulations, indicating a potential takeover or acquisition activity.
Dr. Agarwal's Health Care Limited
Dr. Agarwal's Health Care Limited has allotted 43,155 equity shares to eligible employees under the Employees Stock Option Scheme 2022, increasing the company's paid-up equity share capital to ₹ 31,70,26,183.